ArticleMolecular cancer therapeutics2022

ABBV-011, A Novel, Calicheamicin-Based Antibody-Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors.

Wolf R Wiedemeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.